Skip to main content

Table 1 Baseline characteristic of patients

From: Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching

   Unmatched Propensity score matched
Characteristic Cohort (n = 922) Inpatient Statin (n = 250) Non Statin (n = 672) p-value Inpatient Statin (n = 229) Non Statin (n = 229) p-value
Age, (years) n (%)
 Median (IQR) 66 (56–73.25) 66 (59–75) 65 (54–73) 0.007 66 (58.5–75) 68 (59–75) 0.49
 18–30 26 (2.8) 0 26 (3.9) 0 5 (2.2)
 31–45 81 (8.8) 10 (4) 71 (10.6) 8 (3.5) 20 (8.7)
 46–64 320 (34.7) 91 (36.4) 229 (34.1) 87 (38) 63 (27.5)
 ≥ 65 495 (53.7) 149 (59.6) 346 (51.5) 134 (58.5) 141 (61.6)
Sex, n (%)
 Male 490 (53.1) 139 (55.6) 351 (52.2) 0.36 123 (53.7) 128 (55.9) 0.64
 Female 432 (46.9) 111 (44.4) 321 (47.8) 106 (46.3) 101 (44.1)
Race, n (%)
 Blacks 688 (74.6) 179 (71.6) 509 (75.7) 0.2 167 (72.9) 172 (75.1) 0.59
 Other races 234 (25.4) 71 (28.4) 163 (24.3) 62 (27.1) 57 (24.9)
BMI
 Median (IQR) 29.4 (25.2–35.9) 29.25 (24.4–34.83) 29.4 (25.6–36.5) 0.17 29.7 (24.9–35.1) 29.27 (25.65–35.35) 0.78
 < 18.5 (underweight) 28 (3) 8 (3.2) 20 (3) 6 (2.6) 8 (3.5)
 18.5–24.9 (normal) 195 (21.1) 65 (26) 130 (19.3) 53 (23.1) 44 (19.2)
 25–29.9 (overweight) 266 (28.9) 61 (24.4) 205 (30.5) 57 (24.9) 73 (31.9)
 ≥ 30 (obese) 432 (46.9) 116 (46.4) 316 (47) 113 (49.3) 104 (45.4)
Comorbidities, n (%)
 Preexisting lung diseases 304 (33) 87 (34.8) 217 (32.3) 0.47 81 (35.4) 74 (32.3) 0.49
 Coronary artery disease 214 (23.2) 94 (37.6) 120 (17.9)  < 0.001 86 (37.6) 76 (33.2) 0.33
 Hypertension 756 (82) 233 (93.2) 523 (77.8)  < 0.001 213 (93) 200 (87.3) 0.04
 Diabetes Mellitus 413 (44.8) 136 (54.4) 277 (41.2)  < 0.001 126 (55) 119 (52) 0.51
 Hyperlipidemia 280 (30.4) 127 (50.8) 153 (22.8)  < 0.001 109 (47.6) 101 (44.1) 0.45
 Congestive Heart Failure 135 (14.6) 56 (22.4) 79 (11.8)  < 0.001 51 (22.3) 46 (20.1) 0.57
 Stroke 100 (10.8) 48 (19.2) 52 (7.7)  < 0.001 39 (17) 37 (16.2) 0.8
 Cancer 88 (9.5) 18 (7.2) 70 (10.4) 0.14 18 (7.9) 16 (7) 0.72
 Chronic liver disease 35 (3.8) 3 (1.2) 32 (4.8) 0.01 3 (1.3) 5 (2.2) 0.48
 Chronic kidney disease 110 (11.9) 41 (16.4) 69 (10.3) 0.01 36 (15.7) 37 (16.2) 0.9
 ESRD on dialysis 98 (10.6) 31 (12.4) 67 (10) 0.29 30 (13.1) 20 (8.8) 0.13
 Smoking 387 (42) 117 (46.8) 270 (40.2) 0.07 103 (45) 112 (48.9) 0.4
Insurance
 Uninsured 9 (1) 3 (1.2) 6 (0.9) 0.03 3 (1.3) 4 (1.7) 0.83
 Medicaid 242 (26.2) 52 (20.8) 190 (28.3) 50 (21.8) 45 (19.7)
 Medicare 595 (64.5) 180 (72) 415 (61.8) 161 (70.3) 168 (73.4)
 Private 76 (8.2) 15 (6) 61 (9.1) 15 (6.6) 12 (5.2)
Days from symptom onset to hospital presentation
 0–5 649 (70.4) 185 (74) 464 (69) 0.2 173 (75.5) 168 (73.4) 0.78
 6–10 160 (917.4) 39 (15.6) 121 (18) 39 (17) 39 (17)
 11–15 55 (6) 10 (4) 45 (6.7) 10 (4.4) 15 (6.6)
 16 +  18 (2) 7 (2.8) 11 (1.6) 7 (3.1) 7 (3.1)
CURB-65 at presentation
 0 222 (24.1) 36 (14.4) 186 (27.7)  < 0.001 35 (15.3) 44 (19.2) 0.44
 1 280 (30.4) 81 (32.4) 199 (29.6) 76 (33.2) 62 (27.1)
 2 275 (29.8) 88 (35.2) 187 (27.8) 82 (35.8) 80 (34.9)
 3 110 (11.9) 38 (15.2) 72 (10.7) 30 (13.1) 32 (14)
 4 20 (2.2) 4 (1.6) 16 (2.4) 3 (1.3) 8 (3.5)
 5 12 (1.3) 3 (1.2) 9 (1.3) 3 (1.3) 3 91.3)